Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Term ID:4551
Name:Generalized Epilepsy With Febrile Seizures Plus, Type 2
Definition:
Alternative IDs:OMIM:604403
ParentIDs:MESH:D003294|MESH:D004829
TreeNumbers:C10.228.140.490.375/C565810 |C10.228.140.490.650/C565810
Synonyms:FEB3A, INCLUDED |GEFSP2 |GEFS, Type 2 |GEFS+, TYPE 2;GEFS+2 FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED
Slim Mappings:Nervous system disease
Reference: MedGen: C565810
MeSH: C565810
OMIM: 604403;

Genes: SCN1A;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0011463Childhood onset
3 HP:0010819Atonic seizure
4 HP:0002069Bilateral tonic-clonic seizure
5 HP:0002373Febrile seizure (within the age range of 3 months to 6 years)
6 HP:0006813Focal hemiclonic seizure
7 HP:0002123Generalized myoclonic seizure
8 HP:0002121Generalized non-motor (absence) seizure
9 HP:0010818Generalized tonic seizure
10 HP:0003828Variable expressivity
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_006920.4(SCN1A):c.5764delC (p.Arg1922Glufs)-1-Pathogenic587780446RCV000118238; NMedGen:C1858673,OMIM:6044032166847988166847988NM_006920.4:c.5764delCNP_008851.3:p.Arg1922GlufsNC_000002.11:g.166847988delG-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.5506delC (p.Leu1836Serfs)-1-Pathogenic398123599RCV000176630; RCV000079590; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166848246166848246NM_006920.4:c.5506delCNP_008851.3:p.Leu1836SerfsNC_000002.11:g.166848246delG-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.5108T>C (p.Met1703Thr)-1-Likely pathogenic121917949RCV000176631; RCV000079588; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166848644166848644NM_006920.4:c.5108T>CNP_008851.3:p.Met1703ThrNC_000002.11:g.166848644A>C,NC_000002.11:g.166848644A>G-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.5093C>T (p.Thr1698Ile)-1-Pathogenic121918629RCV000013754; RCV000013755; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166848659166848659NM_006920.4:c.5093C>TNP_008851.3:p.Thr1698IleNC_000002.11:g.166848659G>AOMIM Allelic Variant:182389.0013,UniProtKB (variants):VAR_029717C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.4935C>G (p.Ile1645Met)-1-Pathogenic121917955RCV000059433; RCV000013746; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166848817166848817NM_006920.4:c.4935C>GNP_008851.3:p.Ile1645MetNC_000002.11:g.166848817G>COMIM Allelic Variant:182389.0005,UniProtKB (variants):VAR_014273C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.4910G>A (p.Arg1637His)-1-Pathogenic121918622RCV000059521; RCV000013742; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166848842166848842NM_006920.4:c.4910G>ANP_008851.3:p.Arg1637HisNC_000002.11:g.166848842C>A,NC_000002.11:g.166848842C>TOMIM Allelic Variant:182389.0001,UniProtKB (variants):VAR_010111C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.4874G>A (p.Arg1625Gln)-1-Likely pathogenic;Pathogenic121917995RCV000059431; RCV000176634; RCV000188983; NMedGen:C1853372,OMIM:606369; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166848878166848878NM_006920.4:c.4874G>ANP_008851.3:p.Arg1625GlnNC_000002.11:g.166848878C>TUniProtKB (variants):VAR_043369C1853372 606369 Epileptic encephalopathy Lennox-Gastaut type; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided
NM_006920.4(SCN1A):c.4798G>T (p.Val1600Phe)-1-Pathogenic121918630RCV000013756; RCV000013757; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166850677166850677NM_006920.4:c.4798G>TNP_008851.3:p.Val1600PheNC_000002.11:g.166850677C>AOMIM Allelic Variant:182389.0014,UniProtKB (variants):VAR_029706C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.4411A>C (p.Ile1471Leu)-1-Likely pathogenic794729200RCV000184019; NMedGen:C1858673,OMIM:6044032166854580166854580NM_006920.4:c.4411A>CNP_008851.3:p.Ile1471LeuNC_000002.11:g.166854580T>G-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.4251+2T>C-1-Pathogenic398123595RCV000176178; RCV000079583; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166858980166858980NM_006920.4:c.4251+2T>CNC_000002.11:g.166858980A>GHGMD:CS1211442C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.4250T>C (p.Val1417Ala)-1-Pathogenic121918627RCV000059508; RCV000013752; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166858983166858983NM_006920.4:c.4250T>CNP_008851.3:p.Val1417AlaNC_000002.11:g.166858983A>GOMIM Allelic Variant:182389.0011,UniProtKB (variants):VAR_029700C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.4186C>T (p.Arg1396Ter)-1-Pathogenic398123593RCV000176177; RCV000079581; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166859047166859047NM_006920.4:c.4186C>TNP_008851.3:p.Arg1396TerNC_000002.11:g.166859047G>AHGMD:CM024308C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.4024G>C (p.Val1342Leu)-1-Pathogenic121917954RCV000059409; RCV000013745; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166859209166859209NM_006920.4:c.4024G>CNP_008851.3:p.Val1342LeuNC_000002.11:g.166859209C>GOMIM Allelic Variant:182389.0004,UniProtKB (variants):VAR_014272C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.3776A>C (p.Lys1259Thr)-1-Pathogenic121918626RCV000059501; RCV000013751; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166868689166868689NM_006920.4:c.3776A>CNP_008851.3:p.Lys1259ThrNC_000002.11:g.166868689T>GOMIM Allelic Variant:182389.0010,UniProtKB (variants):VAR_014271C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_001165963.1(SCN1A):c.3733C>T (p.Arg1245Ter)-1-Pathogenic727504136RCV000153888; RCV000153889; RCV000188925; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166868765166868765NM_001165963.1:c.3733C>TNP_001159435.1:p.Arg1245TerNC_000002.11:g.166868765G>AHGMD:CM031739C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.3613G>A (p.Glu1205Lys)-1-Likely pathogenic398123590RCV000175286; RCV000079575; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166870313166870313NM_006920.4:c.3613G>ANP_008851.3:p.Glu1205LysNC_000002.11:g.166870313C>T-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.3577T>C (p.Trp1193Arg)-1-Pathogenic121917930RCV000059402; RCV000013747; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166870349166870349NM_006920.4:c.3577T>CNP_008851.3:p.Trp1193ArgNC_000002.11:g.166870349A>GOMIM Allelic Variant:182389.0006,UniProtKB (variants):VAR_014270C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.2923_2924delCT (p.Phe976Serfs)6323SCN1APathogenic794729207RCV000184026; NMedGen:C1858673,OMIM:6044032166893030166893031NM_006920.4:c.2923_2924delCTNP_008851.3:p.Phe976SerfsNC_000002.11:g.166893030_166893031delAG-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.2803C>T (p.Arg935Cys)6323SCN1APathogenic121918775RCV000059481; RCV000118240; RCV000189085; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166894396166894396NM_006920.4:c.2803C>TNP_008851.3:p.Arg935CysNC_000002.11:g.166894396G>A,NC_000002.11:g.166894396G>TUniProtKB (variants):VAR_029682C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.2758C>T (p.Arg920Cys)6323SCN1ALikely pathogenic;Pathogenic121918788RCV000059475; RCV000153894; RCV000188897; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166894441166894441NM_006920.4:c.2758C>TNP_008851.3:p.Arg920CysNC_000002.11:g.166894441G>AHGMD:CM024303,UniProtKB (variants):VAR_029678C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.2591C>T (p.Thr864Met)6323SCN1APathogenic121918623RCV000059471; RCV000013743; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166894608166894608NM_006920.4:c.2591C>TNP_008851.3:p.Thr864MetNC_000002.11:g.166894608G>A,NC_000002.11:g.166894608G>TOMIM Allelic Variant:182389.0002,UniProtKB (variants):VAR_010110C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.2557-2A>G6323SCN1APathogenic727504140RCV000153895; RCV000153896; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166894644166894644NM_006920.4:c.2557-2A>GNC_000002.11:g.166894644T>C-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_001165963.1(SCN1A):c.2584C>T (p.Arg862Ter)6323SCN1APathogenic397514459RCV000174714; RCV000174713; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166895938166895938NM_001165963.1:c.2584C>TNP_001159435.1:p.Arg862TerNC_000002.11:g.166895938G>A,NC_000002.11:g.166895938G>C-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.2543G>A (p.Arg848His)6323SCN1APathogenic398123588RCV000174715; RCV000079567; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166895946166895946NM_006920.4:c.2543G>ANP_008851.3:p.Arg848HisNC_000002.11:g.166895946C>THGMD:CM117761C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_001165963.1(SCN1A):c.2420dupT (p.Thr808Hisfs)6323SCN1APathogenic786200989RCV000153897; RCV000153898; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166896102166896102NM_001165963.1:c.2420dupTNP_001159435.1:p.Thr808HisfsNC_000002.11:g.166896102dupA-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.2181G>A (p.Trp727Ter)6323SCN1APathogenic786205214RCV000170444; NMedGen:C1858673,OMIM:6044032166897942166897942NM_006920.4:c.2181G>ANP_008851.3:p.Trp727TerNC_000002.11:g.166897942C>T-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_001165963.1(SCN1A):c.2134C>T (p.Arg712Ter)6323SCN1APathogenic794726730RCV000174291; RCV000174292; RCV000188886; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166898844166898844NM_001165963.1:c.2134C>TNP_001159435.1:p.Arg712TerNC_000002.11:g.166898844G>A-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_001165963.1(SCN1A):c.1837C>T (p.Arg613Ter)6323SCN1APathogenic398123585RCV000174048; RCV000079562; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166900385166900385NM_001165963.1:c.1837C>TNP_001159435.1:p.Arg613TerNC_000002.11:g.166900385G>AHGMD:CM065453C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.1766A>T (p.Asp589Val)6323SCN1ALikely pathogenic398123584RCV000174049; RCV000079560; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166900456166900456NM_006920.4:c.1766A>TNP_008851.3:p.Asp589ValNC_000002.11:g.166900456T>A-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.1162delT (p.Tyr388Ilefs)6323SCN1APathogenic398123580RCV000180210; RCV000079552; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166904145166904145NM_006920.4:c.1162delTNP_008851.3:p.Tyr388IlefsNC_000002.11:g.166904145delA-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.1029-1G>C6323SCN1APathogenic398123579RCV000180211; RCV000079550; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:6044032166904279166904279NM_006920.4:c.1029-1G>CNC_000002.11:g.166904279C>G-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.830delG (p.Cys277Leufs)6323SCN1APathogenic794727786RCV000179375; NMedGen:C1858673,OMIM:6044032166908363166908363NM_006920.4:c.830delGNP_008851.3:p.Cys277LeufsNC_000002.11:g.166908363delC-C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_001165963.1(SCN1A):c.664C>T (p.Arg222Ter)6323SCN1APathogenic121918624RCV000032604; RCV000150094; RCV000188841; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166909392166909392NM_001165963.1:c.664C>TNP_001159435.1:p.Arg222TerNC_000002.11:g.166909392G>AHGMD:CM013787,OMIM Allelic Variant:182389.0008C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided; C0751122 607208 Severe myoclonic epilepsy in infancy
NM_006920.4(SCN1A):c.563A>T (p.Asp188Val)6323SCN1APathogenic121917953RCV000059448; RCV000013744; NMedGen:C1858672,OMIM:604233; MedGen:C1858673,OMIM:6044032166911187166911187NM_006920.4:c.563A>TNP_008851.3:p.Asp188ValNC_000002.11:g.166911187T>AOMIM Allelic Variant:182389.0003,UniProtKB (variants):VAR_014267C1858672 604233 Generalized epilepsy with febrile seizures plus, type 1; C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.434T>C (p.Met145Thr)6323SCN1APathogenic121918631RCV000013758; NMedGen:C1858673,OMIM:6044032166912960166912960NM_006920.4:c.434T>CNP_008851.3:p.Met145ThrNC_000002.11:g.166912960A>G,NC_000002.11:g.166912960A>TOMIM Allelic Variant:182389.0015,UniProtKB (variants):VAR_025366C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2
NM_006920.4(SCN1A):c.302G>A (p.Arg101Gln)6323SCN1APathogenic121917918RCV000059400; RCV000150095; RCV000188829; NMedGen:C0751122,OMIM:607208,SNOMED CT:230437002; MedGen:C1858673,OMIM:604403; MedGen:CN2218092166915161166915161NM_006920.4:c.302G>ANP_008851.3:p.Arg101GlnNC_000002.11:g.166915161C>THGMD:CM044039,UniProtKB (variants):VAR_029661C1858673 604403 Generalized epilepsy with febrile seizures plus, type 2; CN221809 not provided; C0751122 607208 Severe myoclonic epilepsy in infancy